Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: Preliminary results of a phase I trial-Reference-Cited by-同舟云学术

Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: Preliminary results of a phase I trial

Published:2002-05 Issue:5 Volume:35 Page:930-936
ISSN:0741-5214
Container-title:Journal of Vascular Surgery
language:en
Short-container-title:Journal of Vascular Surgery

Author:

Comerota Anthony J.,Throm Richard C.,Miller Kathryn A.,Henry Timothy,Chronos Nicolas,Laird John,Sequeira Rafael,Kent Craig K.,Bacchetta Matthew,Goldman Corey,Salenius Juha-Pekka,Schmieder Frank A.,Pilsudski Richard

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Surgery

Reference39 articles.

1. Critical limb ischemia;TASC Working Group;J Vasc Surg,2000

2. Six-year prospective mulitcenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions;Veith;J Vasc Surg,1986

3. Treatment of critical limb ischemia;TASC Working Group;J Vasc Surg,2000

4. Assessment of quality of life of patients with severe ischemia as a result of infrainguinal arterial occlusive disease;Albers;J Vasc Surg,1992

5. Double-blinded controlled clinical trial of ancrod for ischemic rest pain of the leg;Lowe;Angiology,1982

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy for polygenic or complex diseases;Biomarker Research;2024-09-04

2. Codon-Optimized and de novo–Synthesized E-Selectin/AAV2 Dose–Response Study for Vascular Regeneration Gene Therapy;Annals of Surgery;2024-07-08

3. Therapeutic Angiogenesis and Cardiovascular Disease: A Review;Cardiology in Review;2024-05-30

4. Role of endothelial Raptor in abnormal arteriogenesis after lower limb ischaemia in type 2 diabetes;Cardiovascular Research;2024-05-09

5. Delivery of DNA-Based Therapeutics for Treatment of Chronic Diseases;Pharmaceutics;2024-04-13